We added EGF to stimulate cell proliferation in gastric cancer cells and found that the proliferation rate was significantly accelerated; yet, after the addition of silkworm carboxypeptidase inhibitor, the rapid increase in the number of gastric cancer cells was curbed, although the number of cells was still higher than that of the previous EGF-free treatments. Here, EGF is linked to gastric cancer.